Rosie Watson

From CoNFLict to Confidence: Solving a Diagnostic Dilemma Using Neurofilament Light – A Case Report

PM Loveland, D Eratne, S Holper, N Yassi, R Watson

Journal article  |  2023  |  European Medical Journal

Distinguishing neurodegenerative from primary psychiatric conditions is often challenging for clinicians, particularly when assess..

Cerebral amyloid angiopathy: clinical presentations and management challenges in the Australian context

Oshi Swarup, James LL Barker, Rosie Watson, Stephen MM Davis, Bruce CV Campbell, Nawaf Yassi

Journal article  |  2023  |  INTERNAL MEDICINE JOURNAL

Cerebral amyloid angiopathy (CAA) is a disease with several clinical manifestations. It is characterised by amyloid-beta depositio..

Diagnostic challenges for dementia in Australia: are blood‐based biomarkers the solution?

Paula M Loveland, Rosie Watson, Nawaf Yassi

Journal article  |  2022  |  Internal Medicine Journal

Amyloid-beta (A beta)-Related Cerebral Amyloid Angiopathy Causing Lobar Hemorrhage Decades After Childhood Neurosurgery

Jeremy F Kellie, Bruce C Campbell, Rosie Watson, Adrian J Praeger, Girish Nair, Anand Murugasu, Christopher C Rowe, Colin L Masters, Steven Collins, Catriona McLean, Nawaf Yassi

Journal article  |  2022  |  STROKE

BACKGROUND: Recent reports raise the possibility of cerebral amyloid angiopathy (CAA) leading to intracerebral hemorrhage in young..

Tau as a Biomarker of Neurodegeneration

Sarah Holper, Rosie Watson, Nawaf Yassi

Journal article  |  2022  |  INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Less than 50 years since tau was first isolated from a porcine brain, its detection in femtolitre concentrations in biological flu..

Treatment initiation for parkinson's disease in Australia 2013-2018: a nation-wide study.

Marjaana Koponen, J Simon Bell, Samanta Lalic, Rosie Watson, Anne M Koivisto, Jenni Ilomäki

Journal article  |  2022  |  BMC Geriatr

BACKGROUND: Guidelines highlight the importance of an individualized approach to treatment initiation for Parkinson's disease. Our..

Association between amyloid-beta deposition and cortical thickness in dementia with Lewy bodies

Kai Sin Chin, Sanuji Gajamange, Patricia M Desmond, Victor L Villemagne, Christopher C Rowe, Leonid Churilov, Nawaf Yassi, Rosie Watson

Journal article  |  2022  |  AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

OBJECTIVE: Amyloid-beta often co-exists in dementia with Lewy bodies, but its clinical relevance in dementia with Lewy bodies rema..

Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in clinical settings

Dhamidhu Eratne, Samantha M Loi, Li Qiao-Xin, Christiane Stehmann, Charles B Malpas, Alexander Santillo, Shorena Janelidze, Claire Cadwallader, Nirbaanjot Walia, Blair Ney, Victoria Lewis, Matteo Senesi, Christopher Fowler, Amelia McGlade, Shiji Varghese, Parsa Ravanfar, Wendy Kelso, Sarah Farrand, Michael Keem, Matthew Kang, et al.

Journal article  |  2022  |  ALZHEIMERS & DEMENTIA

INTRODUCTION: Many patients with cognitive and neuropsychiatric symptoms face diagnostic delay and misdiagnosis. We investigated w..

The influence of cerebrovascular disease in dementia with Lewy bodies and Parkinson's disease dementia

Zina Hijazi, Nawaf Yassi, John T O'Brien, Rosie Watson

Journal article  |  2022  |  EUROPEAN JOURNAL OF NEUROLOGY

BACKGROUND AND PURPOSE: Lewy body dementia (LBD), including dementia with Lewy bodies (DLB) and Parkinson's disease dementia, is a..

Cardiovascular Risk Associated with Poorer Memory in Middle-Aged Adults from the Healthy Brain Project

Nawaf Yassi, Matthew P Pase, Rachel F Buckley, Emily Rosenich, Rosie Watson, Paul Maruff, Yen Ying Lim

Journal article  |  2022  |  JOURNAL OF ALZHEIMERS DISEASE

BACKGROUND: Midlife cardiovascular risk factors (CVRF) are associated with reduced cognition and an increased risk of dementia. OB..